Skip to main content

Advertisement

SpringerLink
Log in

Activated peripheral blood mononuclear cells detected by murine monoclonal antibodies to proliferating cell nuclear antigen in active lupus patients

  • Original Articles
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Hybridoma producing monoclonal antibody to proliferating cell nuclear antigen (PCNA/cyclin) (TOB7, IgG1 κ) was newly established. Using TOB7, PCNA was detected in the peripheral blood mononuclear cells (PBMC) in patients with systemic lupus erythematosus (SLE). Forty-four of 58 patients with SLE had PBMC expressing PCNA. The percentage of PCNA-positive PBMC in patients with SLE was 0–20% (mean: 2.63%) which was significantly higher (P<0.01) compared with normal controls (mean: 0.18%), patients with rheumatoid arthritis (mean: 0.83%), and patients with mixed connective tissue disease (mean: 0.38%). Patients with high numbers of PCNA positive PBMC tended to complicate pulmonary disorders (P<0.005), especially pulmonary fibrosis (P<0.005). In addition, the percentage of PCNA-positive cells in SLE patients correlated with the disease activity (r=0.45,P<0.01). The lymphocyte subsets of PCNA-positive PBMC were examined, and most of those cells belonged to CD4- or CD8-positive T-cell populations in three lupus patients. Our findings indicate that PCNA-positive activated PBMC are present in SLE patients and the percentage of PCNA-positive PBMC may be used as an indicator of disease activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Miyachi K, Fritzler MJ, Tan EM: Autoantibody to a nuclear antigen in proliferating cells. J Immunol 121:2228–2234, 1978

    Google Scholar 

  2. Fritzler MJ, McCarty GA, Ryan JP, Kinsella TD: Clinical features of patients with antibodies directed against proliferating cell nuclear antigen. Arth Rheum 26:140–145, 1983

    Google Scholar 

  3. Ohata N: Clinical significance of antibodies to proliferating cell nuclear antigen. Rheumachi 27:79–87, 1987

    Google Scholar 

  4. Takasaki Y, Fishwild D, Tan EM: Characterization of proliferating cell nuclear antigen recognized by autoantibodies in lupus sera. J Exp Med 159:981–992, 1984

    Google Scholar 

  5. Ogata K, Ogata Y, Nakamura RM, Tan EM: Purification and N-terminal amino acid sequence of proliferating cell nuclear antigen (PCNA)/cyclin and development of ELISA for anti-PCNA antibodies. J Immunol 135:2623–2627, 1985

    Google Scholar 

  6. Takasaki Y, Deng JS, Tan EM: A nuclear antigen associated with cell proliferation and blast transformation. J Exp Med 154:1899–1909, 1981

    Google Scholar 

  7. Mathews MB, Bernstein RM, Franza BR Jr, Garrels JI: Identity of the proliferating cell nuclear antigen and cyclin. Nature 309:374–376, 1984

    Google Scholar 

  8. Bravo R, Frank R, Blundell PA, Bravo HM: Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ. Nature 326:515–517, 1987

    Google Scholar 

  9. Prelich G, Tan CK, Kostura M, Mathews MB, So AG, Downey KM, Stillman B: Functional identity of proliferating cell nuclear antigen and a DNA polymerase-δ auxiliary protein. Nature 326:517–520, 1987

    Google Scholar 

  10. Smetana K, Gyorkey F, Chan PK, Tan EM: Proliferating cell nuclear antigen (PCNA) and human malignant tumor nuclear antigen (HMTNA) in nucleoi of human hematological malignancies. Blut 46:133–141, 1983

    Google Scholar 

  11. Takasaki Y, Robinson WA, Tan EM: Proliferating cell nuclear antigen in blast crisis cells of patients with chronic myeloid leukemia. J Natl Cancer Inst 73:655–661, 1984

    Google Scholar 

  12. Ogata K, Kurki P, Celis JE, Nakamura RM, Tan EM: Monoclonal antibody to a nuclear protein (PCNA/cyclin) associated with DNA replication. Exp Cell Res 168:475–486, 1987

    Google Scholar 

  13. Kurki P, Ogata K, Tan EM: Monoclonal antibodies to proliferating cell nuclear antigen (PCNA)/cyclin as probes for proliferating cells by immunofluorescence microscopy and flow cytometry. J Immnol Methods 109:49–59, 1988

    Google Scholar 

  14. Thaete LG, Ahnen DJ, Malkinson AM: Proliferating cell nuclear antigen (PCNA/Cyclin) immunocytochemistry as a labeling index in mouse lung tissues. Cell Tissue Res 256:167–173, 1989

    Google Scholar 

  15. Kurki P, Ogata K, Robinson CA, Williams GW, Tan EM: Proliferating cell nuclear antigen (PCNA) as a marker for a subset of activated human T-lymphocytes in blood and synovial fluid. Arth Rheum 29:586 (abstr B 24), 1986

    Google Scholar 

  16. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schallen JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. J Clin Invest 76:1865–1870, 1985

    Google Scholar 

  17. Ropes MW, Bennett EA, Cobb S, Jacox R, Jessary R: 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 9:175–179, 1958

    Google Scholar 

  18. Lahita RG, Bradlow HL, Ginzler E, Pang S, New M: Low plasma androgens in women with systemic lupus erythematosus. Arth Rheum 30:241–248, 1987

    Google Scholar 

  19. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR: Mixed connective tissue disease: An apparently distinct rheumatic disease syndrome associated with a specific antibody to extractable nuclear antigen (ENA). Am J Med 52:148–157, 1972

    Google Scholar 

  20. Oi V, Herzenberg LA:In Selected Methods in Cellular Immunology, BB Mishell, E Shigii (eds). San Francisco, WH Freeman, 1980, p 351

    Google Scholar 

  21. Boyum A: Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest 21:97–105, 1968

    Google Scholar 

  22. Campbell DH, Garvey FS, Cremer NE, Sussdorf DH: Preparation of fluorescein-conjugated gamma globulin.In Methods in Immunology. New York, WA Benjamin, 1970, p 351

    Google Scholar 

  23. Farr RS: A quantitative immunochemical measure of the primary interaction between I*BSA and antibody. J Infect Dis 103:239–262, 1958

    Google Scholar 

  24. Northway JD, Tan EM: Differentiation of antinuclear antibodies giving speckled staining patterns in immunofluorescence. Clin Immunol 1:140–154, 1972

    Google Scholar 

  25. Lowry OH, Rosebrough NJ, Farr AL: Protein measurement with Folin phenol reagent. J Biol Chem 193:265–275, 1951

    Google Scholar 

  26. Jasin HE, Ziff M: Immunoglobulin synthesis by peripheral blood cells in systemic lupus erythematosus. Arth Rheum 18:219–228, 1975

    Google Scholar 

  27. Letwin DA, Cohen PL, Winfield JB: Characterization of warm-reactive IgG anti-lymphocyte antibody in systemic lupus erythematosus. Relative specificity for mitogenactivated T cells and their soluble products. J Immunol 130:181–186, 1983

    Google Scholar 

  28. Fu SM, Chiroazzi N, Wang CY, Montaxeri G, Kunkel HG, Ko HS, Gottlieb AB: Ia bearing T lymphocytes in man: Their identification and role in the generation of allogenic helper activity. J Exp Med 148:1423–1428, 1978

    Google Scholar 

  29. Trowbridge IS, Omary MB: Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc Natl Acad Sci USA 78:3039–3043, 1981

    Google Scholar 

  30. Uchiyama T, Broder S, Waldman TA: A monoclonal antibody (anti-Tac) reactive with activated and functional mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac cells. J Immunol 126:1393–1397, 1981

    Google Scholar 

  31. Boumpas DT, Tsokos GC, Mann DL, Eleftheriades EG, Harrs CC, Mark GE: Increased proto-oncogene expression in peripheral blood lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arth Rheum 29:755–760, 1986

    Google Scholar 

  32. Gerdes J, Schwab U, Lemke H, Stein H: Production of a mouse monoclonal antibody reactive with a nuclear antigen associated with cell proliferation. Int J Cancer 31:13–18, 1983

    Google Scholar 

  33. Haynes, BF, Hemler ME, Mann DL, Eisenbarth GS, Shelhamer J, Mostowski HS, Thomas CA, Strominger JL, Fauci AS: Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. J Immunol 126:1409–1413, 1981

    Google Scholar 

  34. Yu DTY, Winchester RJ, Fu SM, Gibofsky A, Ko HS, Kunkel HG: Peripheral blood Ia-positive T cells. J Exp Med 151:91–100, 1980

    Google Scholar 

  35. Kurki P, Lotz M, Ogata K, Tan EM: Proliferating cell nuclear antigen (PCNA)/cyclin in activated human T lymphocytes. J Immunol 138:4114–4120, 1987

    Google Scholar 

  36. Volk HD, Kopp J, Korner IJ, Jahn S, Grunow R, Barthelmes H, Fiebig H: Correlation between the phenotype and the functional capacity of activated T cells in patients with active systemic lupus crythematosus. Scand J Immunol 24:109–114, 1986

    Google Scholar 

  37. Cotner T, Williams JM, Christenson L, Shapiro HM, Strom TB, Strominger J: Simultaneous flow cytemetric analysis of human T cell activation antigen expression and DNA content. J Exp Med 157:461–472, 1983

    Google Scholar 

  38. Blaese RM, Grayson J, Steinberg AD: Increased immunoglobulin-secreting cells in the blood of patients with active systemic lupus erythematosus. Am J Med 69:345–350, 1980

    Google Scholar 

  39. Hirano T: The appearance of Ia+T cells in systemic lupus erythematosus.In Cellular, Molecular and Genetic Approaches to Immunodiagnosis and Immunotherapy, K Kano (ed). Tokyo, University of Tokyo Press, 1987, pp 441–445

    Google Scholar 

  40. Carney WP, Iacovicello V, Hirsch MS: Functional properties of T lymphocytes and their subsets in cytomegalovirus mononucleosis. J Immunol 130:390–393, 1983

    Google Scholar 

  41. Crawford DH, Brickell, P, Tidman N, McConnell I, Hoffband AV, Janossy G: Increased numbers of cells with suppressor T cell phenotype in peripheral blood of patients with infectious mononucleosis. Clin Exp Immunol 43:291–297, 1981

    Google Scholar 

  42. Prelich G, Kostura M, Marshak DR, Mathews MB, Stillman B: The cell-cycle regulated proliferating cell nuclear antigen is required for SV40 DNA replication in vitro. Nature 326:471–475, 1987

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, Department of Internal Medicine, Juntendo University, School of Medicine, Tokyo, Japan

    Atsuko Murashima, Yoshinari Takasaki, Hiroshi Hashimoto & Shunichi Hirose

  2. Department of Pathology, Juntendo University, School of Medicine, Tokyo, Japan

    Makoto Ohgaki & Toshikazu Shirai

  3. Mitsubishi Kasei Corporation, Research Center, Kanagawa, Japan

    Makoto Ohgaki

Authors
  1. Atsuko Murashima
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoshinari Takasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Makoto Ohgaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiroshi Hashimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Toshikazu Shirai
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shunichi Hirose
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murashima, A., Takasaki, Y., Ohgaki, M. et al. Activated peripheral blood mononuclear cells detected by murine monoclonal antibodies to proliferating cell nuclear antigen in active lupus patients. J Clin Immunol 10, 28–37 (1990). https://doi.org/10.1007/BF00917495

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00917495

Key word

Search

Navigation